west syndrome: response to valproate
Clicks: 175
ID: 220816
2012
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.2
/100
175 views
41 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #243 of 263 articles by views in journal of photochemistry and photobiology a: chemistry
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 263 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Management of West syndrome is unsatisfactory. In our clinic we observed that a significant proportion of patients respond to usual dose of valproate. Objective: To prospectively assess the efficacy of valproate in controlling infantile spasms in West syndromeMethods: Consecutive patients presenting with West syndrome to the Pediatric Neurology Clinic or general OPD were enrolled for study. Those who were not on any treatment were given valproate in a dose of 30 mg/kg/day while awaiting investigations. Patients were followed up every 2 weeks. Predefined criteria for definition of West syndrome and response were used. Those showing partial/poor response or relapse on valproate were given hormonal therapy.Results: One hundred children with West syndrome were enrolled. Ninety one children were started on valproate. Of these 36 (39.5%) showed a good response, but 7 later relapsed while on same dose of valproate and 3 were lost to follow up. Later age at onset and typical hypsarrythmia on EEG were associated with good sustained response to valproate while a history of delayed cry at birth was associated with partial or poor response. Sixty two patients who responded poorly to or relapsed on valproate were put on hormonal treatment in addition. Of these 36 (58.1%) had a good response but 11 later relapsed after stopping treatment and 2 were lost to follow up. Conclusions: Valproate may have a role in treatment of West syndrome in a selected group of patients.
| Reference Key |
echandra2012frontierswest
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Surabhi eChandra;Anupama eBhave;Roli eBhargava;Chandrakanta ekumar;Rashmi eKumar |
| Journal | journal of photochemistry and photobiology a: chemistry |
| Year | 2012 |
| DOI |
10.3389/fneur.2012.00166
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.